Johnson & Johnson's (JNJ +2.5%) subsidiary Cordis says European regulators and the FDA have...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Johnson & Johnson's (JNJ +2.5%) subsidiary Cordis says European regulators and the FDA have approved additional sizes for the company's Sleek OTW platform, an ultra-low profile percutaneous transluminal angioplasty dilatation catheter. The device is a highly deliverable balloon catheter designed to treat patients undergoing peripheral angioplasty procedures below the knee.